This XRP News Today roundup starts with the number on the chart: the token is trading near $1.44, up 2.0% in the past 24 hours, after swinging inside a $1.36 to $1.45 range over the same window.
That's a modest move, not a breakout, and it's landing in the same week as two confirmed developments away from the price chart: a regulatory filing changing how a major ETF prices its shares and a fresh date confirmation for a builder event tied to Ripple's biggest annual conference.
Here's the snapshot from CoinGecko as of writing:
| Metric | Value |
| Price | $1.44 |
| 24h Change | +2.0% |
| 24h Range | $1.36 – $1.45 |

Note: Cryptocurrency prices are highly volatile. Price and market data shown here is a snapshot at the time of writing and can change quickly.
Source: CoinGecko Live Data
A 2% daily gain inside a wide intraday range points to a choppy, back-and-forth session rather than one clean move in either direction, which lines up with a week that's carrying more regulatory and ecosystem news than price-specific catalysts.
The bigger story in today's XRP News Today cycle isn't price; it's an ETF filing. Per an 8-K filed with the SEC, 21Shares US LLC entered a licensing agreement with FTSE International Limited on August 20, 2026.
Starting August 27, the 21Shares fund will value its shares and calculate net asset value using the FTSE XRP Index, replacing the CME CF reference rate it has used since launch.
Source: SEC 8-K Filing, 21Shares
This isn't isolated to one fund. Per 21Shares' own announcement, the firm is standardizing its benchmark framework across eight US-listed products, including its Bitcoin, Ethereum, Solana, Sui, Dogecoin, Polkadot, and Hyperliquid funds alongside TOXR, all transitioning to FTSE Russell indices at market open the same day.
Sponsor Fee Timing Shifts To Quarterly
The same 8-K discloses a second change. The Trust amended its sponsor agreement, dated August 26, so the fee 21Shares collects for running the fund moves from weekly payments to at least quarterly, with payment continuing in the fund's underlying asset rather than cash.
The filing frames this as a timing change only, not an adjustment to the fee itself.
The second thread in this XRP News Today update moves away from ETFs entirely.
XRPL Commons confirmed its Ledger Hackathon will run October 24–25 in New York, hosted in partnership with the XRP Ledger Foundation, the weekend directly before Ripple's Swell conference, which runs October 27–29 at The Shed in Hudson Yards, the first year Ripple has merged Swell with its developer-focused Apex summit.
Source: XRPL Commons Hackathon Listing
The event runs four tracks: Protocol Innovation, focused on amendments and core tooling; Agentic Finance, building rails for autonomous on-chain transactions; lending & borrowing, building on the ledger's proposed lending features; and an open Why Not track for any XRPL project.
A three-day Core Dev Bootcamp runs October 20–22 as an on-ramp to the Protocol Innovation track.
Network activity is climbing alongside the hackathon buildup. Seven-day average active addresses on the ledger rose 2.3% to roughly 14,300 daily wallets, according to MSB Intel.

Source: MSB Intel
None of this week's news is a price catalyst on its own, and today's 2% move reflects that: real but unremarkable.
What it does show is an ecosystem moving on two fronts at once, regulated products standardizing how they price the asset, and builder infrastructure lining up ahead of a major industry event two months out.
Whether the FTSE switch changes how TOXR trades once it takes effect, and whether the hackathon produces anything that reaches mainnet, are both things only the coming weeks will confirm.
Today's XRP News Today headline isn't a dramatic price swing; it's a 2% move inside a wide range.
The more substantial developments sit underneath it: 21Shares is standardizing benchmarks across eight funds, including TOXR, a sponsor fee change paid in the underlying asset, and XRPL Commons locking in hackathon dates ahead of Swell.
This article is for educational and informational purposes only and should not be considered financial or investment advice. Always conduct your own research before making investment decisions.